Gennova Biopharmaceuticals Had Filed Its Phase 2 Data with Central Drugs Standard Control ... - Latest Tweet by ANI

Gennova Biopharmaceuticals had filed its phase 2 data with Central Drugs Standard Control Organisation (CDSCO) on Friday. The Omicron specific variant of vaccine is under development & will be ready for human clinical trials, subject to regulatory approvals:A company spokesperson— ANI (@ANI) January 17, 2022

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)